The importance of signaling modulations in obesity, heart disease and fibrosis

College of Medicine – Tucson Department of Cellular and Molecular Medicine

When

Noon – 1 p.m., March 19, 2025

Where

Sarver Heart Center, Room 4137
1501 N Campbell Ave., Tucson, AZ 85724

Event Description

The Department of Cellular and Molecular Medicine Seminar Series presents a talk by Dr. Maria Kontaridis titled “The importance of signaling modulations in obesity, heart disease and fibrosis.” Lunch will be provided.

Presenter Details

Maria Kontaridis, PhD
Executive Director, Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, Director of Research
Masonic Medical Research Institute

Kontaridis is the Executive Director, Gordon K. Moe Professor and Chair of Biomedical Research and Translational Medicine, and the Director of Research at the Masonic Medical Research Institute in Utica, NY. She also holds a part-time faculty appointment as an Associate Professor of Medicine at Harvard Medical School and Beth Israel Deaconess Medical Center, Department of Medicine/Division of Cardiology in Boston, MA. Kontaridis’ research program focuses on the mechanisms underlying congenital heart disease and end-stage heart failure, as well as the processes that lead to abnormal development, aberrant signaling and disease onset of lupus, diabetes/obesity, gastrointestinal disease, autism, and cancer. Her work has been awarded grants from the several national foundations, the American Heart Association, Department of Defense, and the National Institutes of Health, as well as has garnered support from industry and pharmaceutical companies. Kontaridis is the current Chair of the AHA Basic Cardiovascular Sciences Council (BCVS).